Skip to main content

Overview

Dr. Michael W. O'Dell received his Medical Degree in 1985 from Indiana University School of Medicine and completed a residency in Physical Medicine and Rehabilitation at the Hospital of the University of Pennsylvania in 1989.  In 1991, he completed a Fellowship in Brain Injury and Trauma Rehabilitation at Mediplex-Rehabilitation in Camden, New Jersey. Dr. O'Dell currently serves as Chief of Clinical Services and Attending Physiatrist in the Department of Rehabilitation Medicine. He joined NewYork-Presbyterian Hospital in 2001, prior to which he held several academic appointments, medical directorships and administrative positions. He is nationally recognized in the rehabilitation of brain injury and neurological diseases.

Dr. O'Dell is a Professor of Clinical Rehabilitation Medicine at Weill Medical College of Cornell University and Adjunct Professor of Clinical Rehabilitation Medicine at Columbia University College of Physicians and Surgeons. He is a member of the American Academy of Physical Medicine and Rehabilitation (AAPMR).  He serves on the Editorial Board of the Journal of Head Trauma Rehabilitation and is the co-editor of Cancer Rehabilitation: Principles and Practice, published by Demos in 2009. Dr. O'Dell has published over 15 book chapters, over 45 neurological scientific papers, dozens of abstracts, given professional presentations throughout the world in the area of neurological rehabilitation medicine.

Highlights

  1. 1
    PM & R : the journal of injury, function, and rehabilitation · 2021
    PMID: 33583134DOISenior author6 citations
  2. 2
    International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation · 2025
    PMID: 41147602DOIFirst author
  3. 3
    Physiotherapy Canada. Physiotherapie Canada · 2023
    PMID: 40959721PMCID: PMC12392819DOISenior author

Publications

111 publications

Clinical research

1 study
Completed & closed trials (1)
  • PI
    A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging, Multi-Center Trial to Evaluate the Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Upper Limb Spasticity in Adults After Stroke or Traumatic Brain Injury
    PHASE2 · Revance Therapeutics, Inc. · IRB STUDY CLOSURE (as of 2021)
    Upper Limb Spasticity
    NCT03821402

News mentions

  • Awards Recognize Faculty and Student Achievements
    May 26, 2022

    Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care at the institution’s commencement ceremony on May 19 at Carnegie Hall.

Mentoring

1 mentee
  • SM
    Samuel McGowen
    MD mentee · Class of 2025